1、What is Preeclampsia?
Preeclampsia, is a hypertensive disorder of pregnancy that can cause systemic multi-organ damage to pregnant women, which is mainly manifested as hypertension and high protein in the urine (systolic blood pressure ≥ 140mmHg, diastolic blood pressure ≥90mmHg) and high protein in the urine (0.3g/24h). It is one of the leading causes of maternal death, preterm birth, neonatal illness or death.
Preeclampsia is a serious hypertensive disorder of pregnancy, which is seriously harmful to both mother and baby. Pregnant women with preeclampsia are prone to symptoms such as hypertension and proteinuria, which can lead to maternal cardiovascular and cerebrovascular lesions, placental abruption, pulmonary edema and other complications in severe cases, endangering the life safety of mothers and babies.
2、Understanding Eclampsia Tests
sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) are two growth factors that play an important role in the normal course of pregnancy. The sFlt-1 and PlGF ratios were found to be abnormally elevated in patients with preeclampsia and not significantly increased in healthy pregnant women. Therefore, sFlt-1/PlGF, as a novel marker of preeclampsia, is expected to help screen for preeclampsia. Our eclampsia test kit can be used for detection.
3、Benefits of sFlt-1/PlGF screening
Simplicity: The sFlt-1/PlGF screening method is simple and requires only one blood test in the first trimester, helping to improve the accessibility of screening.
Early detection: Studies have shown that sFlt-1/PlGF screening can identify more patients at high risk of preeclampsia, which can help with early intervention and management.
Assess risk: The results of sFlt-1/PlGF screening can be used as an important indicator to assess the risk of preeclampsia and guide individualized medical interventions.
4、Eclampsia Testing Kit Product ：HSCL-5000 equipment
Designing and manufacturing eclampsia chemiluminescence immunoassay analyzer and testing kits that are user-friendly, accurate, and reliable. Our analyzer and test reagents (which are Dry clia reagents), offer the following advantages：
♦Online Consultation and Support: Providing professional medical advice and support online to assist users in understanding their test results. This could include explanations of what different test results mean, and what steps should be taken following the test.
As a novel marker for preeclampsia screening, sFlt-1/PlGF has the advantages of simplicity, early detection and risk assessment. With sFlt-1/PlGF screening (SFlt-1/PIGF Test Kit), we can better identify people at high risk of preeclampsia and provide patients with timely diagnosis and intervention. At the same time, we should also recognize the limitations of sFlt-1/PlGF screening, and comprehensively apply blood pressure, urine protein, electrocardiogram and other indicators to improve the accuracy of screening .
